Short answer
Cardiff Oncology, Inc. (CRDF) filed an 8-K current report with the SEC on February 25, 2026 reporting Item 7.01 (Regulation FD Disclosure). Cardiff Oncology (CRDF) conducting third-party investor/partner meetings using updated corporate slide presentation.
Cardiff Oncology, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Cardiff Oncology (CRDF) conducting third-party investor/partner meetings using updated corporate slide presentation
- Presentation filed as Exhibit 99.1: primary source for pipeline updates, data, or strategic positioning
- Filed under Reg FD to ensure simultaneous public disclosure of material information shared in private meetings
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cardiff Oncology, Inc. 8-K filings
Get the next CRDF 8-K as it lands
Follow CRDF for push alerts, or ask the research agent what this filing means.